Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Guide de suivi des patients atteints de pneumonie SRAS-CoV-2. Propositions de gestion élaborées par la Société de médecine respiratoire de langue française

Archive ouverte

Andréjak, Claire | Blanc, F.-X. | Costes, F. | Crestani, B. | Debieuvre, D. | Perez, T. | Philippe, B. | Plantier, L. | Schlemmer, F. | Sesé, L. | Stach, B. | Uzunhan, Y. | Zanetti, C. | Zysman, M. | Raherison, C. | Maitre, B.

Edité par CCSD ; Elsevier Masson -

International audience. The French-language Respiratory Medicine Society (SPLF) proposes a guide for the follow-up of patients who have presented with SARS-CoV-2 pneumonia. The proposals are based on known data from previous epidemics, on acute lesions observed in SARS-CoV-2 patients and on expert opinion. This guide proposes a follow-up based on three categories of patients: (1) patients managed outside hospital for possible or proven SARS-CoV-2 infection, referred by their physician for persistent dyspnoea; (2) patients hospitalized for SARS-CoV-2 pneumonia in a medical unit; (3) patients hospitalized for SARS-CoV-2 pneumonia in an intensive care unit. The subsequent follow-up will have to be adapted to the initial assessment. This guide emphasises the possibility of others causes of dyspnoea (cardiac, thromboembolic, hyperventilation syndrome...). These proposals may evolve over time as more knowledge becomes available.

Suggestions

Du même auteur

Guide de prise en charge des sequelles respiratoires post infection a SARS-CoV-2. Propositions de prise en charge elaborees par la Societe de Pneumologie de Langue Francaise. Version du 10 novembre 2020.. Guide de prise en charge des sequelles respiratoires post infection a SARS-CoV-2. Propositions de prise en charge elaborees par la Societe de Pneumologie de Langue Francaise. Version du 10 novembre 2020.: Rev Mal Respir

Archive ouverte | Andréjak, Claire | CCSD

International audience. The French-speaking Respiratory Medicine Society (SPLF) proposes a guide for the management of possible respiratory sequelae in patients who have presented with SARS-CoV-2 pneumonia (COVID-19...

M. Xenopi Pulmonary Infection: A Randomized Clinical Trial Comparing Rifampin + Ethambutol + Either Clarithromycin or Moxifloxacin: The Camomy Study

Archive ouverte | Andrejak, Claire | CCSD

Meeting abstract de l'International Conference of the American-Thoracic-Society (ATS 2024), May 17-22, 2024, San Diego, Calif.. International audience. Rationale: Mycobacterium xenopi (MX) pulmonary infections are a...

Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021

Archive ouverte | Zysman, M. | CCSD

International audience

Chargement des enrichissements...